StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Natriumascorbat

Sodium Erythorbate

HCID 23683938
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
134-03-2
Standard-SMILES
O=C1O[C@H]([C@H](O)CO)C([O-])=C1O.[Na+]
InChIKey
PPASLZSBLFJQEF-RKJRWTFHSA-M
Summenformel
C6H7NaO6
Durchschnittliche Molmasse
198,11 g/mol
Monoisotopische Masse
198,01403222

Überblick

Almost odorless fluffy, white to off-white crystalline powder. Used as an antioxidant and preservative.

Namen und Bezeichner

Bevorzugter Name
Sodium Erythorbate
IUPAC
sodium (2R)-2-[(1R)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate
Lokaler Name
Natriumascorbat
Englischer Name
Sodium ascorbate
Summenformel
C6H7NaO6
Molmasse
199.11

Namen und Synonyme

SODIUM ERYTHORBATE6381-77-7Sodium isoascorbateIsonaNeo-cebitateIsoascorbic acid sodium saltMercate 20Sodium D-isoascorbateEribate NAraboascorbic acid, monosodium salt, D-Erythorbic Acid Sodium SaltOZOBAN
Weitere Namen anzeigen
SODIUM L-ASCORBATE(+)-Sodium L-ascorbateL-ASCORBIC ACID SODIUM SALTSodiuM ascorbatE301VITAMIN C SODIUMSodium (R)-2-((S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olateascorbinL-ASCORBIC ACID SODIUMSodium Ascorbate Powder
DTXSID5020570BZ468R6XRDMonosodium D-erythro-hex-2-enonic acid gamma-lactoneDTXCID90570INS NO.316INS-316-D-Erythro-hex-2-enonic acid, gamma-lactone, monosodium saltE-316

Datenbank-Bezeichner

CAS
134-03-2、6381-77-7

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
110 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
2
Schwere Atome
13
Formalladung
0
Komplexität
237

Experimentelle und physikochemische Eigenschaften

Chemical ClassesOther Uses -> Food Additives
Cosmetics · 2 Einträge

Cosmetic ingredients (Sodium Erythorbate) -> CIR (Cosmetic Ingredient Review)

Antioxidant

pH · 2 Einträge

5,5 to 8,0 (10 % aqueous solution)

pH of aqueous solutions of sodium salt between 5 & 6; 10% solution, made from commercial grade, may have pH of 7.2 to 7.9

Food AdditivesANTIMICROBIAL AGENT, ANTIOXIDANT, COLOR OR COLORING ADJUNCT, DOUGH STRENGTHENER, FLOUR TREATING AGENT, OXIDIZING OR REDUCING AGENT, PROCESSING AID, SURFACE-FINISHING AGENT -> FDA Substance added to food
Density1.2 (NTP, 1992) - Denser than water; will sink
Color/FormWhite, free-flowing crystals
Solubility · 4 Einträge

greater than or equal to 100 mg/mL at 64 °F (NTP, 1992)

Freely soluble in water, very slightly soluble in ethanol

Soluble in water

16 g soluble in 100 mL water

Melting Point

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 3 Einträge

This chemical does not meet GHS hazard criteria for 95.6% (370 of 387) of all reports.

Not Classified

Aggregated GHS information provided per 387 reports by companies from 5 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information · 5 Einträge

Chemical: D-Erythro-hex-2-enonic acid, .gamma.-lactone, monosodium salt

Commission Regulation (EC) 1334/2003 (amended)

D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: 2,3-didehydro-3-O-sodio-D-erythro-hexono-1,4-lactone (EC: 228-973-9)

Sodium erythorbate: Does not have an individual approval but may be used under an appropriate group standard

Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Fire PotentialSodium Erythorbate may burn but does not ignite readily
Health HazardsSYMPTOMS: Symptoms of exposure to this compound may include eye and skin irritation.
Hazards SummaryClassified as non-toxic ingestion; [HSDB] In lethal dose studies, rats have diarrhea; Oral LD50 (rat) >5000 mg/kg; [ChemIDplus] A skin and eye irritant; [CAMEO] May cause irritation; [MSDSonline]

Chemie und Industrie

Pharmakologische Informationen

BionecessityErythorbic Acid has 1/20 of the vitamin C activity of its stereoisomer, as does its salt, Sodium Erythorbate. Vitamin C is a cofactor for enzymes involved in collagen biosynthesis...
Metabolism/Metabolites · 1 Eintrag

Male F344 rats (five per group, 6-week-old) were given 5% Sodium Erythorbate in feed for 22 weeks. The rats eliminated totals of 203.3 +/- 33.2 mg/100 mL erythorbic acid and 9.0 +/- 5.1 mg/100 mL dehydroerythorbic acid during the study. Ascorbic acid and dehydroascorbic acid were not detected.

MeSH Pharmacological ClassificationNaturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Absorption, Distribution and Excretion · 1 Eintrag

Male F344 rats (five per group, 6-week-old) were given 5% Sodium Erythorbate in feed for 22 weeks. The rats eliminated totals of 203.3 +/- 33.2 mg/100 mL erythorbic acid and 9.0 +/- 5.1 mg/100 mL dehydroerythorbic acid during the study. Ascorbic acid and dehydroascorbic acid were not detected. Urine pH was 6.98 +/-0.31, which was significantly different from that of rats given basal diet alone (6.31 +/- 0.18; p < 0.05). Urine osmolarity also differed significantly from controls; osmolarity was 1378 +/- 277 mOsmol/kg H20 in rats given Sodium Erythorbate and 1756+/- 200 mOsmol/kg H20 in rats of the control group. Crystals were detected in urine of rats given basal diet and Sodium Erythorbate or basal diet alone.

Verwendung und Herstellung

Uses · 6 Einträge

CIR ingredient: Sodium Erythorbate

Used as preservative and meat curing agent; [HSDB] Used as antioxidant; [Hawley]

For sodium erythorbate (USEPA/OPP Pesticide Code: 116401) there are 0 labels match. /SRP: Not registered for current use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 544414
HRID 544414als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
PubChem CID
23683938
DTXSID
DTXSID5020570
ChEMBL
CHEMBL2309028
UNII
BZ468R6XRD
EC Number
228-973-9
Nikkaji
J2.788.961A
309 to 327 °F (decomposes) (NTP, 1992)
Optical Rotation[α]D/25 10 % (w/v) aqueous solution between + 95° and + 98°
Physical Description · 4 Einträge

Almost odorless fluffy, white to off-white crystalline powder. Used as an antioxidant and preservative.

Dry Powder; CBI

White crystalline solid

White solid; [HSDB] White to off-white odorless solid; [CAMEO] White to off-white odorless crystalline powder; [MSDSonline]

Physikochemische Eigenschaften

Schmelzpunkt
220 °C · 220 °C (dec.)(lit.)
Siedepunkt
235 °C · 235 °C
Dichte
1.66 · 1.66
Dampfdruck
0 Pa · 0Pa at 25℃
Brechungsindex
105.5 ° · 105.5 ° (C=10, H2O)
storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: 50 mg/mL
Aggregatzustand
powder
Farbe
white to slightly yellow
Geruch (Odor)
odorless
PH
7.48 · 7.48(1 mM solution);7.71(10 mM solution);7.64(100 mM solution);7.62(1000 mM solution)
Biologische Quelle
synthetic (organic)
Wasserlöslichkeit
620 g/L · 620 g/L (20 ºC)
Merck
14 · 14,830
BRN
3767246 · 3767246
Stabilität
Stable. Incompatible with strong oxidizing agents.
Kosmetik-Inhaltsstoffe Funktionen
ANTIOXIDANT
InChI
1S/C6H8O6.Na/c7-1-2(8)5-3(9)4(10)6(11)12-5;/h2,5,7-10H,1H2;/q;+1/p-1/t2-,5+;/m0./s1
InChIKey
PPASLZSBLFJQEF-RXSVEWSESA-M
SMILES
[Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-]
LogP
-4.2 at · -4.2 at 21.9℃
CAS Datenbank
134 · 134-03-2(CAS DataBase Reference)
EPA chemische Informationen
Sodium ascorbate (134-03-2)
Reactive Group
Alcohols and Polyols
Special Reports · 2 Einträge

European Chemicals Agency (ECHA); REACH Registration for 2,3-didehydro-3-O-sodio-D-erythro-hexono-1,4-lactone; This is unique source of information on the chemicals manufactured and imported in Europe. It covers their hazardous properties, classification and information on how to use them safely. It is generated by industry in line with their responsibilities under the EU chemicals legislation. This information is a valuable resource for advancing the safe use of chemicals and for the replacement of the most hazardous ones by safer alternatives.[European Chemicals Agency (ECHA); REACH Registration for 2,3-didehydro-3-O-sodio-D-erythro-hexono-1,4-lactone; Available from, as of June 19, 2014: http://echa.europa.eu/]

Cosmetic Ingredient Review; Int. J. Toxicol. 18 (Suppl 3): 1-26 (1999) Final Report on the Safety Assessment of Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate Erythorbic Acid, and Sodium Erythorbate.[Cosmetic Ingredient Review; Int. J. Toxicol. 18 (Suppl 3): 1-26 (1999)]

Reactivity ProfileSODIUM ERYTHORBATE may be sensitive to prolonged exposure to light. Incompatible with strong oxidizing agents (NTP, 1992).
Air and Water ReactionsWater soluble.
Toxic Combustion Products · 2 Einträge

Carbon monoxide and carbon dioxide.

When heated to decomposition it emits acrid smoke and irritating vapors.

Hazard Classes and CategoriesNot Classified

Sicherheit und Schutzausrüstung

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. A water spray may also be used. (NTP, 1992)
First Aid · 1 Eintrag

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Fire Fighting Procedures · 2 Einträge

Firefighters should wear full protective clothing including self-contained breathing apparatus. If possible control runoff from fire control or dilution water to prevent environmental contamination.

Use methods for the surrounding fire including water spray, dry chemical, carbon dioxide, or foam.

Storage Conditions · 1 Eintrag

Keep container tightly closed when not in use. Store containers in a cool, dry location, away from direct sunlight, sources of intense heat, or where freezing is possible. Material should be stored in secondary containers or in a diked area, as appropriate. Store containers away from incompatible chemicals. Storage areas should be made of fireresistant materials. Post warning and "NO SMOKING" signs in storage and use areas, as appropriate.

Cleanup Methods · 2 Einträge

Small releases can be cleaned-up wearing gloves, goggles and suitable body protection. In case of a large spill (in which excessive dusts can be generated), clear the affected area, protect people, and respond with trained personnel. If a vacuum is used for spill clean-up, only an explosion-proof vacuum should be used, due to the possibility for dust explosion. Do not allow the spilled product to enter public drainage system or open water courses. Place all spill residues in an appropriate container and seal. Thoroughly wash the area after a spill or leak clean-up. Avoid contamination of soil, and prevent spill residue from running to groundwater or storm drains.

Stop the flow of material, if this can be done without risk. Contain the discharged material. If sweeping of a contaminated area is necessary use a dust suppressant agent, which does not react with product...

Nonfire Spill Response · 1 Eintrag

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Disposal Methods · 1 Eintrag

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal and plant life; and conformance with environmental and public health regulations.

Preventive Measures · 2 Einträge

SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants. Ensure that the local ventilation moves the contaminant away from the worker.

Handling and storage Handling Procedures All employees who handle this material should be trained to handle it safely. Do not breathe dust. Avoid all contact with skin and eyes. Wherever dust clouds may be generated, eliminate sparks, flames and other ignition sources. Use this product only with adequate ventilation. Areas in which this compound is used should be wiped down periodically so that this substance is not allowed to accumulate. Dry powders can build static electricity charges when subjected to the friction of transfer and mixing operations. Provide adequate precautions, such as electrical grounding and bonding, or inert atmospheres. Wash thoroughly after handling.

Personal Protective Equipment (PPE) · 1 Eintrag

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxikologische Informationen

Interactions · 5 Einträge

Effects of 17 environmental chemicals on urinary bladder carcinogenesis were investigated in rats. Male F-344-rats were given orally 0.05 percent N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN). Rats were fed diets containing 5 percent sodium-saccharin, 2 percent sodium-o-phenylphenate (SOPP), 2 percent butylated-hydroxyanisole (BHA), 5 percent sodium-L-ascorbate (SA), 5 percent ascorbic-acid, 5 percent ascorbic-stearate, 5 percent sodium-erythorbate (SE), 0.8 percent ethoxyquin, 0.02 percent N-nitrosopyrrolidine, 0.2 percent methylhydroquinone, 0.2 percent hydroquinone, 0.2 percent resorcinol, 0.8 percent catechol, 0.5 percent pyrogallol, 0.6 percent carbazole, 0.1 percent quinoline, or 1 percent uric-acid. The left ureter was ligated on day 22. Animals were killed after week 24 and autopsied. Urinary bladder, both kidneys, ureter, and liver were stained for light microscopy examination. No cancer was induced in any rat. Papillary or nodular (PN) hyperplasia was induced by BBN in 7 percent of controls. PN hyperplasia incidences and quantitative values were significantly higher in BBN treated rats fed sodium-saccharin, SOPP, BHA, SA, SE, ethoxyquin, and carbazole. Significant differences in incidences and quantitative values of papillomas were observed in BBN treated rats fed sodium-saccharin, SOPP, BHA, SA, and N-nitrosopyrrolidine. Histopathological changes were found in the left kidney, and dilation in the left pelvic space and ureter were common. No changes were found in the right kidney, ureter, or liver. The authors conclude that the ureter ligation system seems to be suitable as a short term method for the screening of bladder carcinogens and promoters.

Studies were made on the carcinogenic activity of butylated hydroxyanisole (BHA) in rats, mice, and hamsters and the effect of the antioxidants BHA, butylated hydroxytoluene (BHT), ethoxyquin (EQ), sodium L-ascorbate (SA), ascorbic acid (AA), sodium erythorbate (SE), propyl gallate (PG), and alpha-tocopherol, on two-stage chemical carcinogenesis in rats initiated with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), 1,2-dimethylhydrazine (DMH), diethylnitrosamine (DEN), 7,12-dimethylbenz(a)anthracene (DMBA), N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), N-ethyl-N-hydroxyethylnitrosamine (EHEN), or N-methylnitrosourea (MNU). BHA clearly induced squamous cell carcinomas in both the rat and hamster forestomach. The tumorigenic action of crude BHA on the forestomach is largely due to 3-tert-BHA. In two-stage chemical carcinogenesis, BHA promoted MNNG or MNU-initiated forestomach and BBN- or MNU-initiated urinary bladder carcinogenesis and inhibited DEN- or EHEN-initiated liver and DMBA-initiated mammary carcinogenesis. BHT demonstrated promotion potential for urinary bladder and MNU-initiated thyroid carcinogenesis and inhibited DMBA-initiated ear duct carcinogenesis. EQ promoted EHEN-initiated kidney carcinogenesis and inhibited DMBA-initiated mammary and EHEN-initiated liver carcinogenesis. SA promoted forestomach and urinary bladder carcinogenesis and SE likewise enhanced urinary bladder carcinogenesis. alpha-Tocopherol inhibited ear duct carcinogenesis. No effects of any of the antioxidants on glandular stomach carcinogenesis were found. The results clearly demonstrated that antioxidants have different effects (promoting or inhibitory influences) depending on the organ studied and suggest the importance of a whole body approach to their investigation.

Studies were conducted on the carcinogenic activity of butylated hydroxyanisole (BHA) in rats and hamsters. To obtain information concerning the mechanism of action of BHA on the forestomach, the following areas were examined: the effects of 12 phenolic compounds structurally related to BHA on the hamster forestomach, the effects of combinations of BHA and other antioxidants on the rat forestomach, and the metabolism of BHA in the forestomach. Also examined were the effects of several antioxidants on two-stage carcinogenesis in rats. Squamous-cell carcinomas were induced in the forestomach of rats and hamsters fed BHA. In a limited study, 1 of 13 hamsters developed a squamous-cell carcinoma. The tumorigenic action of crude BHA on the forestomach was largely due to the action of 3-tert-BHA. p-tert-Butylphenol and 2-tert-butyl-4-methylphenol induced pronounced hyperplasia and papillomas in the hamster forestomach. BHA and other antioxidants, particularly propyl gallate and ethoxyquin, showed additive effects in inducing forestomach hyperplasia and cytotoxicity. Neither BHA nor its metabolites were found in the forestomach epithelium, although small amounts of metabolites were detected in the stomach contents. Thus, a direct action on the stomach epithelium may be exerted by BHA itself or by metabolites formed on interaction of BHA with gastric juice. BHA enhanced forestomach carcinogenesis initiated in rats by N-methyl-N'-nitro-N-nitrosoguanidine or N-methylnitrosourea (MNU) and enhanced urinary bladder carcinogenesis initiated by MNU or N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN). In contrast, it inhibited carcinogenesis initiated in the liver by either diethylnitrosamine or N-ethyl-N-hydroxyethylnitrosamine (EHEN) and mammary carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene (DMBA). BHT promoted urinary bladder carcinogenesis initiated by BBN or MNU and thyroid carcinogenesis initiated by MNU, but inhibited ear-duct carcinogenesis initiated by DMBA. Ethoxyquin promoted EHEN-initiated kidney carcinogenesis, but inhibited both DMBA-initiated mammary and EHEN-initiated liver carcinogenesis. Sodium ascorbate promoted forestomach and urinary bladder carcinogenesis, and sodium erythorbate also enhanced urinary bladder carcinogenesis. Alpha-tocopherol inhibited ear-duct carcinogenesis. No antioxidants tested had any effect on glandular stomach carcinogenesis. Thus antioxidants have independent modifying (promoting or inhibitory) effects in different organs.

The modifying effects of antioxidants were examined in a carcinogenesis system after N,N-dibutylnitrosamine treatment. Male F344 rats were given 0.05% N,N-dibutylnitrosamine in their drinking water for 4 wk and then treated with basal diet containing 2% butylated hydroxyanisole (BHA), 1% butylated hydroxytoluene (BHT) with 7 ppm vitamin K, 0.8% ethoxyquin, 5% sodium L-ascorbate, 5% sodium erythorbate, or no added chemical for 32 wk. BHA enhanced forestomach carcinogenesis but did not enhance esophageal carcinogenesis. BHT enhanced esophageal carcinogenesis but did not enhance forestomach carcinogenesis. Ethoxyquin significantly enhanced esophageal tumorigenesis. Neither esophageal nor forestomach carcinogenesis was affected by the other antioxidants evaluated. BHA significantly increased DNA synthesis of the forestomach epithelium, whereas BHT tended to increase that of the esophageal epithelium. Thus, BHA and BHT showed different modifying responses in carcinogenesis of the esophagus and forestomach.

For more Interactions (Complete) data for SODIUM ERYTHORBATE (7 total), please visit the HSDB record page.

Toxicity Summary · 2 Einträge

Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

IDENTIFICATION AND USE: Sodium erythorbate forms white, free-flowing crystals. It is a synthetic antioxidant used in food and cosmetic formulations. Foliar application of sodium erythorbate sprays and dusts are used to control young tree decline in citrus trees and to reduce ozone damage to Thompson seedless grapes. It is also used in hydraulic fracturing mixtures to prevent precipitation of metal oxides (iron control). HUMAN EXPOSURE AND TOXICITY: Sodium erythorbate did not cause chromosomal aberrations or sister chromatid exchanges in cultured human embryo fibroblasts. ANIMAL STUDIES: Sodium erythorbate powder did not cause signs of dermal irritation when applied to the intact and abraded skin of rabbits. Instillation of sodium erythorbate powder to the conjunctival sac of rabbits caused slight and transient reddening of the conjunctiva that cleared within 24 hours. Sodium erythorbate did not cause maternal or fetal toxicity when administered to female rats and mice during gestation by oral intubation at dosages up to 1030 mg/kg/day. Developmental toxicity did not occur after pregnant rats were given up to 5% sodium erythorbate in feed during a 13-week teratogenesis study. It produced negative results in the Ames test, the host-mediated assay using S. typhimurium, chromosomal aberration tests using Chinese hamster ovary fibroblasts, the dominant lethal test using rats, and the B. subtilis rec assay. Sodium erythorbate did cause chromosomal aberrations in rat bone marrow cells in vivo. It did not increase the mitotic recombination frequency of S. cerevisiae D3 in vitro, and did not induce heritable translocation heterozygosity in male mice. Rats given 5% sodium erythorbate in feed for 168 days had no morphological alterations such as hyperplasias of the urinary bladder mucosa. It did not enhance the development of rare spontaneous tumors or transform benign tumors to carcinomas after administration to rats in feed at concentrations up to 2.5%. During a 24-week study, rats given 5% sodium erythorbate in feed had simple hyperplasia of the urinary bladder epithelium. The addition of 1.25-2.5% sodium erythorbate to drinking water did not significantly increase tumor incidence, time to death with tumors, or the distribution of tumors in mice after 96 weeks of treatment. It did not have modifying effects on second-stage carcinogenesis of the nonglandular and glandular stomach, colon, liver, kidneys, mammary gland, ear duct, or thyroid gland, but increased the incidence and average number of lesions of the urinary bladder after initiation with N-butyl-(4-hydroxybutyl)nitrosamine. After administration of sodium erythorbate to rats, they eliminated it in urine as erythorbic acid and dehydroerythorbic acid, whereas ascorbic acid and dehydroascorbic acid were not detected. ECOTOXICITY STUDIES: The acute toxicity of the sodium erythorbate to the freshwater fish rainbow trout (Oncorhynchus myldss) has been investigated and gave a 96-Hour LC50 of greater than 100 mg/L (semi-static).

Ecotoxicity Excerpts/AQUATIC SPECIES/ The acute toxicity of the test item to the freshwater fish rainbow trout (Oncorhynchus mykiss) has been investigated and gave a 96-hour LC50 of greater than 100 mg/L. The No Observed Effect Concentration was 100 mg/L.
Ongoing Test Status · 2 Einträge

EPA has released the first beta version (version 0.5) of the Interactive Chemical Safety for Sustainability (iCSS) Dashboard. The beta version of the iCSS Dashboard provides an interactive tool to explore rapid, automated (or in vitro high-throughput) chemical screening data generated by the Toxicity Forecaster (ToxCast) project and the federal Toxicity Testing in the 21st century (Tox21) collaboration. /The title compound was tested by ToxCast and/or Tox21 assays; See the data in Chemical Explorer/[USEPA; ICSS Dashboard Application; Available from, as of June 27, 2014: http://actor.epa.gov/dashboard/]

The following link will take the user to the National Toxicology Program (NTP) Test Agent Search Results page, which tabulates all of the "Standard Toxicology & Carcinogenesis Studies", "Developmental Studies", and "Genetic Toxicity Studies" performed with this chemical. Clicking on the "Testing Status" link will take the user to the status (i.e., in review, in progress, in preparation, on test, completed, etc.) and results of all the studies that the NTP has done on this chemical.[Available from, as of June 30, 2014: http://ntp-apps.niehs.nih.gov/ntp_tox/index.cfm?fuseaction=ntpsearch.searchresults&searchterm=6381-77-7]

Human Toxicity Excerpts/GENOTOXICITY/ Sodium Erythorbate did not cause chromosomal aberrations or sister chromatid exchanges in cultured human embryo fibroblasts.
Artificial Pollution Sources · 1 Eintrag

Sodium erythrobate's production and use as a preservative and antioxidant in foods and cosmetics(1) may result in its release to the environment through various waste streams(SRC); its use to control metal oxide precipitation in hydrofracking(3) will result in its direct release to the environment(SRC).

Non-Human Toxicity Excerpts · 5 Einträge

/LABORATORY ANIMALS: Acute Exposure/ Sodium Erythorbate powder was applied to the intact and abraded skin of six rabbits as a single 2 g/kg dose. A substantial amount of residual compound was observed 24 hours after dosing. No erythema, edema, or other signs of dermal irritation were observed at five of six test sites. One rabbit (abraded skin) had slight (1+) erythema at 24 hours that cleared by 48 hours.

/LABORATORY ANIMALS: Acute Exposure/ Sodium Erythorbate powder (100 mg) was instilled into the conjunctival sac of albino rabbits (10 male and 2 female). The eyes of half of the treated rabbits were rinsed after 5 seconds. Reactions were comparable in rinsed and unrinsed eyes, and were slight and transient in nature. One hour after dosing, two of six unrinsed eyes had congestion of the iris, but the iris reacted normally to light. Varying degrees of redness were observed in the lids of all unrinsed eyes. Slight redness of the nictitating membrane or palpebral conjunctiva at the medial canthus was observed in two unrinsed eyes. At one hour, 1+ iritis was observed in one rinsed eye. Five of six rinsed eyes had slight redness that was limited to only the nictitating membrane in three cases. At 24 hours, all eyes were normal, with the exception of one that had slight reddening of the conjunctiva at the medial canthus. All eyes, rinsed and unrinsed, were normal at 48 hours. The mean ocular irritation scores were 0.33/110 (unrinsed eyes) and 0.17/110 (rinsed eyes)

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Male and female B6C3F1 mice (10 per sex per group) were given drinking water containing 0.625%, 1.25%, 2.5%, 5.0%, or 10% Sodium Erythrobate for 10 weeks. Water and feed were available ad libitum. The untreated control group consisted of 20 male and 20 female mice. By the end of the 1st week of treatment, six male mice and one female mouse of the 10% dosing group had died. Of the male mice given 5.0% Sodium Erythrobate, the average weekly body weight gain was slightly less than 90% that of the control female mice. Body weight gain was increased in female mice given Sodium Erythrobate at a concentration of 5.0%, compared to that of control mice. The maximum tolerated dose (MTD) of Sodium Erythrobate in drinking water was 2.5% for male mice and 5.0% for female mice. Mice given doses greater than the MTD had marked atrophy of both hepatocytes and splenic lymphoid follicles, as well as hydropic degeneration of the renal tubular epithelium. No significant changes were observed in the visceral organs of untreated mice or mice given the dose less than or equal to the MTD of Sodium Erythrobate.

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Sodium Erythorbate powder (2 g/kg) was applied to the intact and abraded skin of six rabbits. Each test site was moistened with physiological saline just prior to dosing. After application of the test material, the exposure area was covered with a double layer of surgical gauze and a piece of rubber dam. The trunk of each rabbit was wrapped in a stockinette, which was secured to the body with tape. The dressings were removed after 24 hour, and the amount of residual sample and signs of localized irritation were noted. The exposure area was cleaned by thorough wiping, and the rabbits were observed for signs of toxicity for 14 days. At 72 hours, a significant amount of residual compound was found at the exposure site of each rabbit. Behavior, body weight gain, and consumption of feed and water were normal, and no signs of toxicity were observed.

Probable Routes of Human Exposure · 2 Einträge

According to the 2006 TSCA Inventory Update Reporting data, the number of persons reasonably likely to be exposed in the industrial manufacturing, processing, and use of sodium erythrobate is 100 to 999; the data may be greatly underestimated(1).

NIOSH (NOES Survey 1981-1983) has statistically estimated that 19,468 workers (6,527 of these were female) were potentially exposed to sodium erythorbate in the US(1). Occupational exposure to sodium erythorbate may occur through inhalation and dermal contact with this compound at workplaces where sodium erythorbate is produced or used. Use data indicate that the general population may be exposed to sodium erythorbate via ingestion of some food products and dermal contact with consumer products containing sodium erythorbate(SRC).

Antidote and Emergency Treatment · 3 Einträge

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/

/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W TKO /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

Non-Human Toxicity ValuesLD50 Rats oral > 5 g/kg

Sicherheitsdaten

wgk
1
tsca
TSCA listed
hs_code
2936270020
RTECS-Nr.
CI7671000
risk_code
68
Toxizität
sce-hmn:lym 100 mmol/L MUREAV 60,321,79
safety_code
24/25
Speicherklasse
11 - Combustible Solids
Giftige Stoffe Daten
134-03-2(Hazardous Substances Data)

Antioxidant and preservative

Used primarily in hair and nail products

Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate, Erythorbic Acid, and Sodium Erythorbate function as antioxidants in cosmetic formulations.

Impurities... The minimum purity of erythorbic acid is 99%. Due to its method of synthesis (starting materials, sucrose and 2-keto-D-gluconate), erythorbic acid is not expected to contain significant impurities. /Erythorbic acid/
U.S. Production · 4 Einträge

2023: 1,000,000 - <2,500,000 lb

D-erythro-Hex-2-enonic acid, .gamma.-lactone, monosodium salt is listed as a High Production Volume (HPV) chemical (65FR81686). Chemicals listed as HPV were produced in or imported into the U.S. in >1 million pounds in 1990 and/or 1994. The HPV list is based on the 1990 Inventory Update Rule. (IUR) (40 CFR part 710 subpart B; 51FR21438).

Production volumes for non-confidential chemicals reported under the Inventory Update Rule.[Table#2063]

Production volume for non-confidential chemicals reported under the 2006 Inventory Update Rule. Chemical: D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt. Aggregated National Production Volume: 1 to < 10 million pounds.

Consumer UsesNot Known or Reasonably Ascertainable
Industry UsesNot Known or Reasonably Ascertainable
Methods of ManufacturingSodium Erythorbate is prepared from D-glucose by a combination of biosynthesis and chemical synthesis via the intermediate 2-keto-D-gluconic acid.
Formulations/PreparationsGrades: Technical; FCC /Food Chemical Codex/
Use Classification · 4 Einträge

Food additives

Food Additives -> ANTIOXIDANT -> JECFA Functional Classes

Food Additives -> ANTIOXIDANT -> JECFA Functional Classes

Cosmetics -> Antioxidant

General Manufacturing Information · 3 Einträge

Food, beverage, and tobacco product manufacturing

D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt (1:1): ACTIVE

TO ACCELERATE COLOR FIXING IN CURED PORK & BEEF CUTS & IN CURED, COMMINUTED MEAT FOOD PRODUCTS; 87.5 OUNCES/100 GAL PICKLE @ 10% PUMP LEVEL; 7/8 OUNCES/100 LB OF MEAT OR MEAT BY-PRODUCT; NO SIGNIFICANT AMT OF MOISTURE TO BE ADDED TO PRODUCT. MEAT INSPECTION DIVISION OF THE US DEPT OF AGRICULTURE. /FROM TABLE/

Anwendungen · 1 Eintrag

VerwendenSodium Ascorbate is an antioxidant that is the sodium form of ascorbic acid. it is soluble in water and provides a nonacidic taste. a 10% aqueous solution has a ph of 7.3–7.6. in water, it readily reacts with atmospheric oxygen and other oxidizing agents, making it valuable as an antioxidant. one part sodium ascorbate is equivalent to 1.09 parts of sodium erythorbate. see ascorbic acid.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

AscorbinsureNatriumhydrogencarbonatPropan-2-ol

Nachgelagerte Produkte

Ascorbinsure
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: Sodium ascorbate is an organic sodium salt resulting from the replacement of the proton from the 3-hydroxy group of ascorbic acid by a sodium ion. It has a role as a food antioxidant, a flour treatment agent, a coenzyme, a plant metabolite, a human metabolite, a Daphnia magna metabolite and a reducing agent. It is an organic sodium salt and a vitamin C. It contains a L-ascorbate.

For more Non-Human Toxicity Excerpts (Complete) data for SODIUM ERYTHORBATE (16 total), please visit the HSDB record page.